A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds

<div>Schematic of CFA experimental design for H460 and MCF7 cells. Cells were treated for 3 days, or for 10 days with or without a 3-day delay. The arrows indicate medium changes with fresh drugs every 72 hours. A similar design was used for two additional cell lines (A549 and MDA-MB-231 cells).</div>

International Journal of Cell Biology

fig1

Figure 1

Figure 1: A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds 

Figure 1 | A Short Post-Reattachment Ultrasensitive Window of Time in Human Cancer Cells as Therapeutic Target of Prolonged Low-Dose Administration of Specific Compounds 